Literature DB >> 9531618

Membrane phospholipid asymmetry in human thalassemia.

F A Kuypers1, J Yuan, R A Lewis, L M Snyder, C R Kiefer, A Bunyaratvej, S Fucharoen, L Ma, L Styles, K de Jong, S L Schrier.   

Abstract

Phospholipid asymmetry in the red blood cell (RBC) lipid bilayer is well maintained during the life of the cell, with phosphatidylserine (PS) virtually exclusively located in the inner monolayer. Loss of phospholipid asymmetry, and consequently exposure of PS, is thought to play an important role in red cell pathology. The anemia in the human thalassemias is caused by a combination of ineffective erythropoiesis (intramedullary hemolysis) and a decreased survival of adult RBCs in the peripheral blood. This premature destruction of the thalassemic RBC could in part be due to a loss of phospholipid asymmetry, because cells that expose PS are recognized and removed by macrophages. In addition, PS exposure can play a role in the hypercoagulable state reported to exist in severe beta-thalassemia intermedia. We describe PS exposure in RBCs of 56 comparably anemic patients with different genetic backgrounds of the alpha- or beta-thalassemia phenotype. The use of fluorescently labeled annexin V allowed us to determine loss of phospholipid asymmetry in individual cells. Our data indicate that in a number of thalassemic patients, subpopulations of red cells circulate that expose PS on their outer surface. The number of such cells can vary dramatically from patient to patient, from as low as that found in normal controls (less than 0.2%) up to 20%. Analysis by fluorescent microscopy of beta-thalassemic RBCs indicates that PS on the outer leaflet is distributed either over the entire membrane or localized in areas possibly related to regions rich in membrane-bound alpha-globin chains. We hypothesize that these membrane sites in which iron carrying globin chains accumulate and cause oxidative damage, could be important in the loss of membrane lipid organization. In conclusion, we report the presence of PS-exposing subpopulations of thalassemic RBC that are most likely physiologically important, because they could provide a surface for enhancing hemostasis as recently reported, and because such exposure may mediate the rapid removal of these RBCs from the circulation, thereby contributing to the anemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531618

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

2.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

3.  Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.

Authors:  Ilaria V Libani; Ella C Guy; Luca Melchiori; Raffaella Schiro; Pedro Ramos; Laura Breda; Thomas Scholzen; Amy Chadburn; YiFang Liu; Margrit Kernbach; Bettina Baron-Lühr; Matteo Porotto; Maria de Sousa; Eliezer A Rachmilewitz; John D Hood; M Domenica Cappellini; Patricia J Giardina; Robert W Grady; Johannes Gerdes; Stefano Rivella
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113

Review 4.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

5.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

6.  Peroxiredoxin-2 expression is increased in beta-thalassemic mouse red cells but is displaced from the membrane as a marker of oxidative stress.

Authors:  Alessandro Matte; Philip S Low; Franco Turrini; Mariarita Bertoldi; Maria Estela Campanella; Daniela Spano; Antonella Pantaleo; Angela Siciliano; Lucia De Franceschi
Journal:  Free Radic Biol Med       Date:  2010-05-19       Impact factor: 7.376

7.  Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice.

Authors:  Kanitta Srinoun; Saovaros Svasti; Worrakavee Chumworathayee; Jim Vadolas; Phantip Vattanaviboon; Suthat Fucharoen; Pranee Winichagoon
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

Review 8.  Red cell membrane: past, present, and future.

Authors:  Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

9.  Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

Authors:  Sylvia T Singer; Elliott P Vichinsky; Sandra Larkin; Nancy Olivieri; Nancy Sweeters; Frans A Kuypers
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

10.  Beneficial effect of aurothiomalate on murine malaria.

Authors:  Ioana Alesutan; Diwakar Bobbala; Syed M Qadri; Adriana Estremera; Michael Föller; Florian Lang
Journal:  Malar J       Date:  2010-05-07       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.